Phaarmasia Ltd. benchmarking: Performance to industry peers

Financial

	Phaarmasia	Samrat Pharmachem	Kabra Drugs
Operational Metrics
Financials
5 yr Average ROE	0.46 %	18.86 %	36.01 %
5yr average Equity Multiplier	2.3	1.83	-0.87
5yr Average Asset Turnover Ratio	0.96	2.61	0.0
5yr Avg Net Profit Margin	-4.04 %	3.87 %	0.0
Price to Book	5.96	0.92	2.39
P/E	3.62	0.0	14.37
5yr Avg Cash Conversion Cycle	-236.72 Days	58.79 Days	0.0
Inventory Days	79.69 Days	28.98 Days	0.0
Days Receivable	83.55 Days	80.32 Days	0.0
Days Payable	340.86 Days	46.76 Days	0.0
5yr Average Interest Coverage Ratio	-92.68	16.47	-1068.45
5yr Avg ROCE	-8.87 %	27.43 %	21.53 %
5yr Avg Operating Profit Margin	-5.39 %	5.58 %	0.0
5 yr average Debt to Equity	0.0	0.21	-1.45
5yr CAGR Net Profit	n/a	5.93 %	43.36 %
5yr Average Return on Assets	-3.86 %	10.3 %	-21.34 %
Shareholdings
Promoter Holding	73.51 %	49.09 %	0.0
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.45 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0